Zonisamide cotreatment delays striatal dopamine transporter reduction in Parkinson disease: A retrospective, observational cohort study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Zonisamide cotreatment delays striatal dopamine transporter reduction in Parkinson disease: A retrospective, observational cohort study

Published:2018-08 Issue: Volume:391 Page:5-9
ISSN:0022-510X
Container-title:Journal of the Neurological Sciences
language:en
Short-container-title:Journal of the Neurological Sciences

Author:

Ikeda Ken,Yanagihashi Masaru,Miura Ken,Ishikawa Yuichi,Hirayama Takehisa,Takazawa Takanori,Kano Osamu,Kawabe Kiyokazu,Mizumura Nao,Iwasaki Yasuo

Funder

Sumitomo Dainippon Pharma fund

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology

Reference45 articles.

1. Nigrostriatal dopamine terminal imaging with dopamine transporter SPECT: an update;Tatsch;J. Nucl. Med.,2013

2. Clinical utility of dopamine transporter single photon emission CT (DaT-SPECT) with (123I) ioflupane in diagnosis of parkinsonian syndromes;Bajaj;J. Neurol. Neurosurg. Psychiatry,2013

3. Correlation of striatal dopamine transporter imaging with post mortem substantia nigra cell counts;Kraemmer;Mov. Disord.,2014

4. Dopamine transporter imaging does not predict the number of nigral neurons in Parkinson disease;Saari;Neurology,2017

5. Dopamine transporter brain imaging to assess the effects of pramipexole vs. levodopa on Parkinson disease progression;Parkinson Study Group;JAMA,2002

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neuroinflammation following anti-parkinsonian drugs in early Parkinson’s disease: a longitudinal PET study;Scientific Reports;2024-02-27

2. A systematic review of the potential effects of medications and drugs of abuse on dopamine transporter imaging using [123I]I-FP-CIT SPECT in routine practice;European Journal of Nuclear Medicine and Molecular Imaging;2023-02-27

3. Effective Management of “OFF” Episodes in Parkinson’s Disease: Emerging Treatment Strategies and Unmet Clinical Needs;Neuropsychiatric Disease and Treatment;2023-01

4. Zonisamide’s Efficacy and Safety on Parkinson’s Disease and Dementia with Lewy Bodies: A Meta-Analysis and Systematic Review;BioMed Research International;2022-09-12

5. Cost-Effectiveness of Zonisamide Versus Levetiracetam in Newly Diagnosed Focal Onset Epilepsy in Serbia;Value in Health Regional Issues;2022-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3